Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
‘Blue Pee’ Saga Continues: Scientists Still Skeptical About TauRx Alzheimer’s Pill
Unlocking the Secrets of ‘Superagers’: 3 Insights Into Alzheimer’s Resilience
Can Multivitamins Slow Cognitive Decline By Two Years? Here’s What Experts Say
Insurers Could Deny Coverage to People With Alzheimer’s Risk Genes
Blurred Vision and Hallucinations: The First Signs of a Rare Form of Alzheimer’s
Carrying Alzheimer’s Drugs Into the Brain on Waves of Sound
How AI Is Turbocharging Alzheimer’s Brain Scans
Could Your Smartphone Tell You’re Developing Cognitive Impairment?
TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.01)
Alzheimer’s Drug Decision Pushed: FDA Slows Down on Donanemab
Alzheimer’s May Be Preventable: Neurologists Say These 4 Things Matter Most
Neurologists Warn: Galantamine Brain Supplements Contaminated With Bacteria
Viagra May Cut Dementia Risk—But Don’t Get Too Excited
5 Things You Need to Know About Blood Tests for Alzheimer’s
4 Frustrating Things I Learned Reporting On Alzheimer’s Blood Tests
Previous
14
15
16
Next
Page load link
Go to Top